Close Menu
Home » Oxford Nanopore

Oxford Nanopore

Oxford Nanopore Technologies was founded in 2005 to develop an electronic, single molecule sensing system based on nanopore science. The company now has more than 250 employees from multiple disciplines including nanopore science, molecular biology and applications, informatics, engineering, electronics, manufacturing and commercialization. Oxford Nanopore's instruments — MinIon, PromethIon, and GridIon are adaptable for the analysis of DNA, RNA, proteins, small molecules and other types of molecule.

Oxford Nanopore Facts

 

CEO: Gordon Sanghera

Website: www.nanoporetech.com

Ticker symbol: Privately held

Headquarters: Oxford, UK

Number of employees: 250+

Feb 20, 2020

BC Centre for Disease Control Launches Genomic Study to Track SARS-CoV-2

The British Columbia Centre for Disease Control will use genomic analysis to identify the origins and spread of SARS-CoV-2, formerly known as 2019-nCoV.

Feb 11, 2020

New Algorithms Unlock Targeted Sequencing on Nanopore Platforms

Premium

The methods exploit a feature of Oxford Nanopore's technology that ejects molecules mid-read, enabling a new level of control over human DNA sequencing runs.

Feb 10, 2020

Nanopore Sequencing-Based Mapping Methods Reveal Open Chromatin, Methylation Patterns

Premium

All three methods build on the use of methyltransferases to mark accessible regions of the genome, using nanopore sequencing to detect the modifications.

Feb 05, 2020

Basmati Rice Genome Assemblies Generated Using Nanopore Sequencing

Assemblies of two basmati rice genomes enabled researchers to trace the origins of the rice variety and could help pinpoint desired rice genes for breeding.

Jan 30, 2020

Emerging Proteomic Technologies Could Provide Competition for Mass Spec

Premium

The rise of new protein analysis techniques have some questioning whether mass spec will in coming years retain its dominant position within proteomics.

Jan 29, 2020

Coronavirus Genome Sequencing Finds Distinct Genetic Differences From 2003 SARS Virus

The researchers also found that the virus was closely related to two bat-derived SARS-like coronaviruses collected in China in 2018.

Jan 24, 2020

New Method Captures Higher-Order Chromatin Contacts With Nanopore Sequencing

Premium

Unlike the Hi-C chromosome conformation assay, the Pore-C technique reveals information that's lost with short-read sequencing.

Jan 23, 2020

Diagnostics Developers Leap Into Action on Novel Coronavirus Tests

Premium

Mere weeks after the 2019-nCoV sequence was released, firms, agencies, and research groups have already created PCR-based tests.

Jan 02, 2020

Oxford Nanopore Technologies Raises £109.5M

The UK-based sequencing technology firm raised £29.3 million in capital and sold £80.2 million in secondary shares.

Dec 20, 2019

Nanopore Protein Sequencing Feasibility Demonstrated by French Startup, Collaborators

Premium

Researchers from France's DreamPore and their collaborators used a nanopore to distinguish between 15 of the 20 proteinogenic amino acids.

Pages

The Scan

Ah, That's What It Is

The New York Times looks at companies using genomic tools to try to quickly identify the cause of patients' infections.

Billions Requested

The White House has asked for $2.5 billion in funding to address the COVID-19 outbreak, according to the Associated Press.

What to Do

A resignation at the Marine Biological Laboratory highlights that institutions are unsure of how to handle researchers previously found to have violated codes of conduct, Nature News says.

PNAS Papers on Heart Transplant Rejection, CAR-T Profiling, Thiopurine Toxicity Variants

In PNAS this week: immune responses that affect heart transplant rejection risk, gene variants associated with thiopurine toxicity, and more.

What's Popular?

In Oxford Nanopore

  1. BC Centre for Disease Control Launches Genomic Study to Track SARS-CoV-2

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.